Madeleine Pharmaceuticals Competitors and Similar CompaniesClear all

Madeleine Pharmaceuticals's competitors and similar companies include Impel Pharmaceuticals, Tonix Pharmaceuticals, Precision Medicine Group and ReBio Technologies.

	Madeleine Pharmaceuticals Madeleine Pharmaceuticals is a biotechnology company that provides heart failure therapy solutions.	Impel Pharmaceuticals Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases.	Tonix Pharmaceuticals Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.	Precision Medicine Group Precision Medicine Group (PMG) is a company that specializes in advising clients on clinical trials, drug discovery, and commercialization.	ReBio Technologies ReBio Technologies is a biomedical company that specializes in drug release technologies.
Founding Date	Founding Date 2014	Founding Date 2008	Founding Date 2007	Founding Date 2012	Founding Date 2014
Type	Type Private	Type Public	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare drug development medtech pharma	Tags Healthcare drug development medtech pharma	Tags Healthcare drug development medtech pharma	Tags Business Products & Services advertising brand creation clinical research market research public relations	Tags Healthcare drug development medtech pharma
Locations	Locations Madison, US HQ	Locations Seattle, US HQ	Locations Chatham, US HQ Montréal, CA Dublin, IE Dartmouth, US New York, US San Diego, US	Locations Bethesda, US HQ	Locations Cranleigh, GB HQ Raisio, FI Crawley, GB
Employees	Employees 1	Employees 6710% increase	Employees 1633% increase	Employees 4044% increase	Employees 244% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 5.8 m	Valuation ($) 23.5 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $12.7m (FY, 2022)	Revenue (est.) $13.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $6.5m (FY, 2022)	Cost of goods $6.6m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $6.2m (FY, 2022)	Gross profit $6.5m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($106.3m) (FY, 2022)	Net income ($124m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 108.1m	Total funding raised $ 15.5m	Total funding raised $ 359.7m	Total funding raised N/A

For sources of this data, please see the company profile

View Company Profiles

Impel Pharmaceuticals

Seattle, US

Employees

67↑ 10% increase

Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases.

View company

Tonix Pharmaceuticals

Chatham, US

Employees

16↑ 33% increase

Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.

View company

Precision Medicine Group

Bethesda, US

Precision Medicine Group (PMG) is a company that specializes in advising clients on clinical trials, drug discovery, and commercialization.

View company

ReBio Technologies